J. Gardner

发表

A phase 2, two-stage study of mirvetuximab soravtansine (IMGN853) in combination with pembrolizumab in patients with microsatellite stable (MSS) endometrial cancer (EC).

U. Matulonis, P. Konstantinopoulos, Joyce F. Liu, 2021 .